Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss.
Idiopathic recurrent pregnancy loss (IRPL) is defined by three or more consecutive miscarriages occurring before the twentieth week of gestation as a result of unidentified etiological factors. The results of previous studies have indicated that prothrombotic factors play a pathogenic role in early and late pregnancy. This study aimed to identify inherited prothrombotic and hypofibrinolytic risk factors in Mexican-Mestizo patients with IRPL. Fifty-six women with IRPL and 50 control women with at least two full-term pregnancies and no history of RPL were included in this case-control study. Four prothrombotic (F5 G1691A, F2 G20210A, MTHFR C677T-A1298C) and one hypofibrinolytic (PAI1 4G/5G) restricted fragment length polymorphisms were subjected to molecular analysis. In the case of hypofibrinolytic ACE Ins/Del (I/D), identification was performed by direct PCR. The independent risk correlated with the presence of polymorphisms in IRPL patients was estimated using odds ratio (OR) with a 95% confidence interval (CI). MTHFR 677TT was the most frequent prothrombotic factor in the IRPL group (23%), followed by the compound-heterozygous C677T-A1298C (16%) and heterozygous F2 20210GA (3.6%). The heterozygous ACE I/D (62%) was the main hypofibrinolytic risk factor of IRPL, followed by the homozygote PAI1 4G/4G (18%). The ACE I/D polymorphism was the only significantly different factor among the cases and controls. The dominant genetic model D/D+I/D vs I/I showed an OR (95%CI) of 2.89 (1.22-6.89) and P = 0.019 in Mexican-Mestizo women. The results of this study support an association between the ACE I/D polymorphism and IRPL risk in a Mexican population.
División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.
J J
JJ
López-Jiménez
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.|Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Á
Á
Porras-Dorantes
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.|Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México.
C I
CI
Juárez-Vázquez
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.
J E
JE
García-Ortiz
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.|Escuela de Ciencias, Departamento de Ciencias Químico-Biológicas, Universidad de las Américas, Cholula, Puebla, México.
C A
CA
Fuentes-Chávez
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México.|Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México.
I J
IJ
Lara-Navarro
División de Genética, Centro de Investigación Biomédica de Occidente, IMSS, Guadalajara, Jalisco, México arjaloma@gmail.com.
A R
AR
Jaloma-Cruz
D000026:Abortion, Habitual / Q000235:genetics*; D016022:Case-Control Studies; D003710:Demography; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008800:Mexico; D011247:Pregnancy; D019851:Thrombophilia / Q000235:genetics*